lutetium - CISMeF

Preferred Label : lutetium;

MeSH definition : An element of the rare earth family of metals. It has the atomic symbol Lu, atomic number 71, and atomic weight 175.;

MeSH CAS label : lutetium;

MeSH Related Number : 7439-94-3 (Lutetium);

Registry Number MeSH : 7439-94-3;

MeSH annotation : a rare earth metal; Lu-175; Lu-167-174, 176-180 LUTETIUM (IM) RADIOISOTOPES (IM);

Wikipedia link : https://en.wikipedia.org/wiki/Lutetium;

Codes EINECS : 231-103-0;

Is substance : O;

UNII : 5H0DOZ21UJ;

InChIKey : OHSVLFRHMCKCQY-UHFFFAOYSA-N;

Details

Origin ID

D008187;

UMLS CUI

C0024170;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- lutetium [Substance BNPC]
Currated CISMeF NLP mapping
- Lutetium (substance) [SNOMED CT concept]
- lutetium [Radlex concept]
Indexing information
- ((177)Lu)Lu-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetra(methane-phosphonic acid) [MeSH Supplementary Concept]
- (177Lu)Lu(III)1,4,7,10-tetraazacyclododecane-1,4,7,10-tetra(methane-phosphonic acid) [MeSH Supplementary Concept]
- 177Lu-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) [MeSH Supplementary Concept]
- 177Lu-CHX-A''-DTPA-ABD-(Z(HER2-342))2 [MeSH Supplementary Concept]
- 177Lu-DKFZ-617 [MeSH Supplementary Concept]
- 177Lu-DKFZ-PSMA-617 [MeSH Supplementary Concept]
- 177Lu-DOTA-3-F11 [MeSH Supplementary Concept]
- 177Lu-DOTA-8-aminooctanoylbombesin (7-14)-amide [MeSH Supplementary Concept]
- 177Lu-DOTA-AE105 [MeSH Supplementary Concept]
- 177Lu-DOTA-Glu-Ala-Tyr [MeSH Supplementary Concept]
- 177Lu-DOTA-Phe [MeSH Supplementary Concept]
- 177Lu-DOTA-lanreotide [MeSH Supplementary Concept]
- 177Lu-DOTA-minigastrin 11 [MeSH Supplementary Concept]
- 177Lu-DOTA-octreotate [MeSH Supplementary Concept]
- 177Lu-DOTA-rituximab [MeSH Supplementary Concept]
- 177Lu-octreotate [MeSH Supplementary Concept]
- 177Lu-octreotide, DOTA(0)-Tyr(3)- [MeSH Supplementary Concept]
- 177Lu-pentixather [MeSH Supplementary Concept]
- Pluvicto [MeSH Supplementary Concept]
- bis(phthalocyaninato)lutetium(III) [MeSH Supplementary Concept]
- bombesin(1-14), lysyl(1)(alpha,gamma-folate)-lysyl(3)(177Lu-DOTA)- [MeSH Supplementary Concept]
- lutetium Lu 177 dotatate [MeSH Supplementary Concept]
- lutetium ethylenediaminetetramethylene phosphonic acid [MeSH Supplementary Concept]
- tetulomab tetraxetan lu-177 [MeSH Supplementary Concept]
- tris(1,10-phenanthroline)lutetium(III) [MeSH Supplementary Concept]
Record concept(s)
- lutetium [MeSH concept]
Related MeSH Supplementary Concept(s)
- 177Lu-DKFZ-PSMA-617 [MeSH Supplementary Concept]
- 177Lu-EB-PSMA-617 [MeSH Supplementary Concept]
- LuPO4:Pr(3+) [MeSH Supplementary Concept]
- Lutetium-171 [MeSH Supplementary Concept]
- Lutetium-176 [MeSH Supplementary Concept]
- Lutetium-177 [MeSH Supplementary Concept]
- Pluvicto [MeSH Supplementary Concept]
- dilutetium silicon pentaoxide [MeSH Supplementary Concept]
- lutetium aminophosphonate [MeSH Supplementary Concept]
- lutetium orthosilicate [MeSH Supplementary Concept]
Semantic type(s)
- Element, Ion, or Isotope [UMLS semantic type]
- Inorganic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Lutetium (substance) [SNOMED CT concept]
- lutetium [Substance BNPC]
- lutetium [Radlex concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients